An antidepressant containing a form of the drug ketamine has been added to the Pharmaceutical Benefits Scheme (PBS), making ...

Spravato (esketamine) is a prescription drug that’s approved to treat certain forms of depression. Esketamine comes as a nasal spray that you inhale. Specifically, Spravato is approved by the ...

American Behavioral Clinics (ABC) is proud to announce the launch of SPRAVATO® (esketamine) treatment at its Oak Creek clinic. OAK CREEK, WI, UNITED STATES, May 2, 2025 /EINPresswire.com/ -- American ...

When Samuel Hockey's doctor suggested he try using a form of ketamine to treat his depression, he was curious."I sort of thought, 'This is just a party drug that I've witnessed friends and people take ...

Second, the rollout of SPRAVATO. SPRAVATO is now offered as a treatment option in 75 of our 95 Greenbrook clinics, up from 35 clinics at the beginning of the quarter. This represents 75% of the ...

A groundbreaking nasal spray using a form of ketamine to treat stubborn depression is set to become more accessible and affordable for thousands of Australians. The spray, known as Spravato, will be ...

Johnson & Johnson Chief Executive Joaquin Duato said on Tuesday that tariffs on pharmaceuticals can create supply chain ...

A drug derived from ketamine will be added to the PBS, helping tens of thousands of Australians struggling with depression to access treatment.

Johnson & Johnson and AbbVie are two major U.S. pharmaceutical companies with robust pipelines and global operations. Both ...